Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03912987 · ClinicalTrials.gov registry record

TRIAL READY (Clinical Trial Readiness)

A clinical trial of Amyotrophic Lateral Sclerosis and Frontotemporal Dementia, sponsored by University of Miami.

Active
Registry status
610
Enrollment target
3
Study locations

NCT03912987 is a study of Amyotrophic Lateral Sclerosis and Frontotemporal Dementia that is active but no longer recruiting, run by University of Miami. The registered enrollment target is 610 participants, below the 892-participant average among 102 other Amyotrophic Lateral Sclerosis trials with a reported enrollment target (32% lower). The trial reports 3 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03912987, a study of Amyotrophic Lateral Sclerosis and Frontotemporal Dementia, is active but no longer recruiting, sponsored by University of Miami.

ACTIVE NOT RECRUITING
Registry status
610 participants
Enrollment target
3
Study locations

Study Summary

This study, being conducted under the auspice of the CReATe Consortium, will enroll patients with ALS and related disorders as well as healthy controls, with the goal of facilitating clinical validation of leading biological-fluid based biomarker candidates that may aid therapy development for patients with ALS and related disorders.

Study Locations (3)

Florida

  • University of Miami - Miami

Kansas

  • University of Kansas - Kansas City

Pennsylvania

  • University of Pennsylvania - Philadelphia

Trial Details

FieldValue
Enrollment Target 610 participants
Start Date 2019-01-22
Est. Completion 2026-06

Sponsor

University of Miami

721 total trials

What the Registry Record Tells You About NCT03912987

The ClinicalTrials.gov registry entry for NCT03912987 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 610 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 892-participant average among 102 other Amyotrophic Lateral Sclerosis trials with a reported enrollment target (32% lower). The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.

The record links to 5 conditions, with Amyotrophic Lateral Sclerosis appearing as the primary indexed condition, and to 0 interventions.

NCT03912987 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Florida, Kansas, Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT03912987 about?

NCT03912987 is a clinical study titled "TRIAL READY (Clinical Trial Readiness)". This study, being conducted under the auspice of the CReATe Consortium, will enroll patients with ALS and related disorders as well as healthy controls, with the goal of facilitating clinical validation of leading biological-fluid based biomarker candidates that may aid therapy development for patie...

What is the current status of trial NCT03912987?

This trial is currently active not recruiting. The enrollment target is 610 participants. The study started on 2019-01-22. Estimated completion is 2026-06.

What conditions does trial NCT03912987 study?

This clinical trial studies the following conditions: Amyotrophic Lateral Sclerosis, Frontotemporal Dementia, Primary Lateral Sclerosis, Progressive Muscular Atrophy, ALS-Frontotemporal Dementia.

Who is sponsoring clinical trial NCT03912987?

This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03912987 being conducted?

This trial has 3 study locations across Florida, Kansas, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Amyotrophic Lateral Sclerosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.